Evoke Pharma, Inc.
EVOK
$5.49
$0.081.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.39% | 30.11% | 186.88% | 90.10% | 30.99% |
| Total Receivables | 45.05% | 72.98% | 259.59% | 63.91% | 95.64% |
| Inventory | 17.82% | -9.63% | -7.62% | -2.28% | 6.05% |
| Prepaid Expenses | -24.63% | -25.60% | -17.30% | 287.07% | 3.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.32% | 522.22% | -7.58% | -62.90% | 138.79% |
| Total Current Assets | 31.27% | 30.33% | 152.50% | 79.07% | 35.95% |
|
|
|||||
| Total Current Assets | 31.27% | 30.33% | 152.50% | 79.07% | 35.95% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -47.48% | -- | -- |
| Total Assets | 32.33% | 31.49% | 147.85% | 80.23% | 35.15% |
|
|
|||||
| Total Accounts Payable | 67.81% | 39.10% | 27.00% | 49.30% | 34.24% |
| Total Accrued Expenses | 30.97% | 36.29% | 8.11% | 209.98% | 294.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.28% | 1.23% | 1.19% | 37,213.43% | 9,369.70% |
| Total Finance Division Other Current Liabilities | 31.58% | 17.19% | 0.00% | 95.12% | -- |
| Total Other Current Liabilities | 31.58% | 17.19% | 0.00% | 95.12% | -- |
| Total Current Liabilities | 22.69% | 16.69% | 7.59% | 335.90% | 355.11% |
|
|
|||||
| Total Current Liabilities | 22.69% | 16.69% | 7.59% | 335.90% | 355.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.38% | 17.62% | 8.63% | 11.91% | 12.20% |
|
|
|||||
| Common Stock & APIC | 5.50% | 5.78% | 12.39% | 9.46% | 7.19% |
| Retained Earnings | -4.26% | -4.06% | -4.34% | -5.06% | -5.45% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 64.15% | 67.03% | 372.84% | 602.07% | 394.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 64.15% | 67.03% | 372.84% | 602.07% | 394.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 64.15% | 67.03% | 372.84% | 602.07% | 394.99% |
|
|
|||||